PRESS RELEASE published on 04/18/2026 at 12:00, 4 months 1 day ago Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study Sanofi's Nuvaxovid COVID-19 vaccine demonstrated better tolerability than mNEXSPIKE in a head-to-head study presented at ESCMID Global Congress. Results indicate lower side effects and improved patient experience COVID-19 Sanofi Vaccine Nuvaxovid Tolerability
PRESS RELEASE published on 04/18/2026 at 04:00, 4 months 1 day ago Formation Metals Responds to OTC Markets Request on Recent Promotional Activity Formation Metals Inc. announces response to OTC Markets' request on recent promotional activity. No false/misleading statements found in marketing materials. CEO purchased shares. Company engages third-party marketing firms for services Investor Relations OTC Markets Formation Metals Inc. Promotional Activity Third-party Marketing Firms
PRESS RELEASE published on 04/18/2026 at 02:00, 4 months 2 days ago AI/ML Innovations Announces Completion of Share Issuance AI/ML Innovations Inc. completes share for debt issuance with service providers, insiders purchase majority shares. Subject Shares subject to statutory hold period AI/ML Innovations Inc. Share Issuance Insiders Debt Statutory Hold Period
PRESS RELEASE published on 04/18/2026 at 01:35, 4 months 2 days ago Medicure Announces Resignation of President and Chief Operating Officer Medicure Inc. announces resignation of President and COO, Dr. Neil Owens. CEO Dr. Albert D. Friesen to assume responsibilities. Company remains focused on strategic priorities for the future Pharmaceuticals Resignation Healthcare Medicure Inc. Leadership
PRESS RELEASE published on 04/18/2026 at 01:00, 4 months 2 days ago Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development Onco-Innovations appoints Dr. Islam Mohamed as CMO and Stephen M. Novak as Chief of R&D, aiming to enhance clinical and development capabilities for advancing ONC010. Strategic leadership additions for Onco's transition to clinical-stage execution Appointment Clinical Development R&D Onco-Innovations ONC010
PRESS RELEASE published on 04/18/2026 at 00:05, 4 months 2 days ago ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds Study reveals maternal RSV vaccination significantly reduces infant hospitalization risk by over 80% according to major UKHSA research presented at ESCMID Global 2026 ESCMID Global 2026 UKHSA Study Maternal RSV Vaccination Infant Hospitalization Risk RSV Impact On Infants
PRESS RELEASE published on 04/18/2026 at 00:00, 4 months 2 days ago Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia Redwood & Aidos launch 'Track and Trace' AI initiative to combat opioid crisis. Analytical platform aims to enhance public safety and health response Opioid Crisis Redwood AI AI Initiative Aidos Innovations Track And Trace
PRESS RELEASE published on 04/17/2026 at 23:37, 4 months 2 days ago Rektron Group Inc. Announces Appointment of a New Director Richard Elliot-Square appointed as director of Rektron Group Inc. bringing extensive experience in global markets. Rektron focuses on sustainable commodity trading and infrastructure Global Markets Sustainable Supply Chain Commodity Trading Rektron Group Inc. Richard Elliot-Square
PRESS RELEASE published on 04/17/2026 at 23:00, 4 months 2 days ago AIP Realty Trust Closes Third Tranche of Non-Brokered Offering of Preferred Units AIP Realty Trust completes third tranche of non-brokered private placement issuing 1,367,945 Preferred Units - Series B Convertible at US$0.50 per unit for aggregate gross proceeds of US$683,973 Private Placement AIP Realty Trust Preferred Units AllTrades Transaction Series B Convertible
PRESS RELEASE published on 04/17/2026 at 22:30, 4 months 2 days ago Vulcan Minerals Inc. - Grant of Incentive Stock Options Vulcan Minerals Inc. grants 2,550,000 stock options to directors & employees at $0.23 each. Company has strategic land positions & holds shares in Atlas Salt Inc. Seeking safe harbor Stock Options Newfoundland Atlas Salt Inc. Exploration Company Vulcan Minerals Inc.
Published on 08/20/2026 at 02:22, 1 hour 11 minutes ago Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 00:40, 2 hours 53 minutes ago Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 5 hours 33 minutes ago Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 6 hours 58 minutes ago Revive Therapeutics Announces Proposed Shares for Debt Settlement
Published on 08/20/2026 at 02:44, 48 minutes ago Quarterly Report for Q2 and Interim Consolidated Financial Statements with Notes for the period from 1 January to 30 June 2026.
Published on 08/20/2026 at 01:45, 1 hour 48 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 Annual results – Delivers on guidance and progresses key strategic actions
Published on 08/18/2026 at 18:00, 1 day 9 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 9 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 16 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 16 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 7 hours ago Aéroports de Paris S.A - July 2026 traffic figures